Company Info
Year Established2020
Contacts
Katie FanningPresident & CEO
Kristine Swiderek PhD
CDO
Courtney Crane PhD
Senior VP, Research
Steven Gillis PhD
Chair
Company Description
Mozart is developing CD8 Treg cell modulators for the treatment of autoimmune and inflammatory diseases.